skip to Main Content

January 9, 2020
After Cuomo Speech, NY Health Orgs Including TAG Warn that Governor’s Health Plan Falls Short
Statement / Press
TAG, as part of the Save NY Public Health Campaign, called out Governor Cuomo’s recently announced Medicaid cuts and other failures to adequately address health and health equity in his January 8, 2020 “State of the State” address.

January 9, 2020
Good COPs or Bad COPs: Promoting Interventions for Coinfections and AIDS in 2020 PEPFAR Country Operational Plans (COPs)
Webinar / Presentation
On Wednesday, January 22, join Treatment Action Group (TAG), Médecins Sans Frontières (MSF), Access Campaign, and Health GAP, IMPAACT4TB, and AVAC for a webinar on how to engage in PEPFAR COPs advocacy and promote the prioritization of interventions that address HIV coinfections and AIDS.

January 6, 2020
Open Letter: Time to Lower the Price of Xpert Cartridges to $5
Letter / Comment
TAG joined 156 organizations and individuals to demand that Cepheid lower the price of Xpert tests for TB, HIV, HCV and other diseases to improve access to rapid, accurate diagnostic testing.

December 16, 2019
TAG Comment on Cures 2.0 Call to Action
Letter / Comment
TAG submitted comments to the offices of Representative Diana DeGette and Representative Fred Upton in response to their call to action regarding a 21st Century Cures Act 2.0 legislation. This proposed Cures 2.0 legislation must strengthen FDA’s stringent regulatory authority to ensure that medicines are safe, effective, and accessible for…

December 10, 2019
2019 TAG Update
TAG’s work in 2019 demonstrated our leadership towards an end to HIV, hepatitis C, and tuberculosis through hard-hitting, science-based activism. Excerpts of the media coverage we received walk you through a remarkable year of TAG’s work.

December 10, 2019
TB R&D Report 2019
TB R&D Report
TAG’s latest report on global funding for TB research and development (R&D), published in collaboration with the Stop TB Partnership, presents new data on TB R&D funding in 2018 and analyzes trends in funding since 2005.

December 5, 2019
Treatment Action Group Applauds Indian TB Activists in Opposing Patents for Critical TB Prevention Drugs
Statement / Press
Treatment Action Group (TAG) applauds the legal actions undertaken by our colleagues from the Delhi Network of Positive People (DNP+) and tuberculosis (TB) survivor and activist Ganesh Acharya of Mumbai, with support from the Third World Network (TWN), contesting two patent applications on combinations of two decades-old TB medicines filed…

November 19, 2019
TAGline November 2019
Vote Your ConSCIENCE: Elevating Health Justice in the 2020 Elections. 2020 marks the eighth U.S. presidential election cycle since Treatment Action Group’s founding in 1992. A hallmark of our activism has been to prepare for each presidential and congressional election cycle strategically, to ensure that whoever is elected, and whoever…

October 31, 2019
Protestors Demand Cepheid Halve the Price of GeneXpert TB Tests to US$5
Statement / Press
The high cost of GeneXpert tests for tuberculosis (TB) leaves open a critical gap in the diagnosis of TB and fails to consider volume of sales and public investments in the development of GeneXpert Media contacts (Hyderabad): David Branigan, +1 857 350 7128,; Shailly Gupta, +41 79 203 13…

October 31, 2019
A Lower Price for Rifapentine Is Just a Start – Communities Need More Than Discounts to Access TB Preventive Therapy
Letter / Comment
October 31, 2019 — Civil society and community-based organizations issued this letter welcoming the availability of lower-priced rifapentine, which is an essential medicine for preventing TB. However,  while all the organizations agree that this discount is a step forward, they’re concerned that it doesn’t apply to all countries. Read/Download the…

Back To Top